Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease.

冠心病患者冠状动脉内 sCD40L 和 hsCRP 浓度梯度

阅读:7
作者:Wang Ying, Li Li, Tan Hong-Wei, Yu Guang-Sheng, Ma Zhi-Yong, Zhao Yu Xia, Zhang Yun
BACKGROUND: Recent studies indicated that local inflammation played a pivotal role in the pathogenesis of coronary heart disease. Soluble CD40 ligand (sCD40L) and hsC- reactive protein (hsCRP) are important inflammatory mediators. However, whether they can reflect local coronary inflammation is unclear. HYPOTHESIS: We hypothesized that transcoronary concentration gradient of sCD40L could reflect local inflammation in patients with coronary heart disease (CHD) more reliably. METHODS: Forty subjects were divided into unstable angina pectoris (UAP) group (n=20), stable angina pectoris (SAP) group (n=10), and controls (n=10). Blood samples were collected from the coronary sinus (CS), aortic root (AO), and femoral vein (FV). The coronary circulation was expressed as CS-AO difference, while system circulation was expressed as FV-AO difference. sCD40L and hs-CRP were measured. RESULTS: Complex lesions were more frequent in the UAP group than in the SAP group (85% vs. 40%, p < 0.05). CS-AO differences of sCD40L were much greater in the UAP group than in the SAP or control groups, and were greatly higher than FV-AO difference in UAP group (465.49 +/- 247.85 pg/mL vs. -14.94 +/- 83.41 pg/mL; 465.49 +/- 247.85 pg/mL vs. -7.66 +/- 78.54 pg/mL; 465.49 +/- 247.85 pg/mL vs. -7.99 +/- 141.34 pg/mL, all p < 0.001). CS-AO differences of sCD40L were higher in patients with complex lesions than with smooth lesions (657.86 +/- 384.76 pg/mL vs. 317.62 +/- 409.98 pg/mL, p < 0.01). There were no significant differences of CS-AO in hs-CRP among the three groups. CONCLUSIONS: In patients with CHD, the transcoronary concentration gradient of sCD40L is more sensitive than hsCRP, and sCD40L possibly a better marker of local inflammation and plaque instability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。